MEFS Exchange course & Symposium- ESHRE2014

 MEFS Exchange course & Symposium- ESHRE2014

30^th Annual Meeting – ESHRE 2014 – Munich/Germany, 29 June – 2 July 2014

Middle East Fertility Society – Pre-congress course 29 June 2014

Course title:

Fertility preservation in women: Facts and dilemmas

Course co-ordinator(s):

Johnny Awwad (Lebanon) and Mohammad Aboulghar (Egypt)

Course description:

Fertility preservation refers to the management approach aimed at preserving and restoring fertility in women undergoing treatment for cancer. It is a substantial quality of life issue in cancer survivors. It may also benefit other clinical conditions, such as incipient ovarian failure and ovarian ageing in women.

This course aims to provide an updated review on the medical and surgical means to reduce the devastating effects of cancer treatment on ovarian function; the current scientific and clinical development of fertility preservation strategies; and the ethical and legal challenges ahead.

To achieve these objectives, a panel of distinguished researchers and scholars has agreed to share with the audience their expertise and knowledge, laying grounds for an exceptional opportunity for exchange and networking.

Target audience:

- Reproductive Endocrinologists and Fertility Specialists

- Biologists involved in assisted reproductive technologies

- Oncologists

- Oncology nurses

- Psychologists and Social workers

Educational needs and expected outcomes

At the completion of this pre-congress course, participants should be able to:

1. Explain the effects of cancer treatment on ovarian function and reproduction
2. Describe the most recent clinical collection techniques associated with oocyte cryopreservation
3. Evaluate the current status of ovarian tissue cryopreservation and transplantation
4. Assess the cost-effectiveness of social egg banking
5. Recognize the psychological, ethical, and legal challenges related to fertility preservation
6. Provide informed counseling to women with cancer about fertility preservation options

Course type:

Advanced

Programme:

09.00 - 09.25       Fertility in female cancer survivors: Pathophysiology and impact on ovarian reserve - Tommaso Falcone (USA)

09.25 - 09.50      Mechanisms of chemotherapy induced ovarian damage: implications for future treatments  -  Kutluk Oktay (USA)

09.50 - 10.15      Minimally Invasive approaches to Fertility Preservation - Tommaso Falcone (USA)

10.15 - 10.30       Discussion

10.30 - 11.00       Coffee break

11.00 - 11.30       Fertility preservation in young women with breast cancer -  Kutluk Oktay (USA)

11.30 - 11.45       Discussion

11.45 - 12.15       Practice guidelines for fertility preservation in cancer patients - Samuel Kim (USA)

12.15 - 12.30       Discussion

12.30 - 13.30       Lunch

13.30 - 13.55      Ovarian tissue cryopreservation: Current achievements - Jacques Donnez (Belgium)

13.55 - 14.20      Current dilemmas with heterotopic ovarian transplantation: fertility or futility - Samuel Kim (USA)

14.20 - 14.45      Age Specific Success of Oocyte Cryopreservation: How to counsel your patient - Kutluk Oktay (USA)

14.45 - 15.00       Discussion

15.00 - 15.30       Coffee break

15.30 - 16.00       Ethical and moral dilemmas in social egg banking - Jacques Donnez (Belgium)

16.00 - 16.15       Discussion

16.15 - 16.45       The current fertility preservation consultation model: Are we adequately informing cancer patients of their options? -Johnny Awwad (Lebanon)

16.45 - 17.00       Discussion

17:00 – 17:05      Concluding Remarks